James Gregory

James Gregory has a broad research background in molecular biology, biochemistry, protein engineering, microbiology, and immunology. He completed his BS in biochemistry at Miami University (Oxford, OH) and received his PhD in biology from the University of California, San Diego for his studies on the spatial and temporal regulation of bacterial cell division.  During his postdoctoral studies, James developed transmission blocking vaccines (TBVs) against malaria using a novel algal expression platform and was awarded the Blasker Science and Technology fellowship for this work. He continued these studies as an Instructor at the Icahn School of Medicine at Mount Sinai where he re-purposed the algal platform for oral vaccines and protein therapeutics. In his  role as a Staff Scientist at the New York Genome Center, James was focused on technology development and neurodegenerative disease modeling using human induced pluripotent stem cells (hiPSCs). He has specific interests in developing methods for targeted long-read sequencing using PacBio and Oxford Nanopore and methods to resolve cell-type specific gene expression in complex in vitro neural co-cultures.